Companies: 10,795·Total market cap: $144.5T
PAVmed Inc.

PAVmed Inc.

PAVMNASDAQHealthcare● Active
$5.18
$-0.27(-4.95%)
Market Cap$2781852
P/E Ratio
52W High$28.44
52W Low$5.1

PAVmed Inc. (PAVM) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · PAVM · as of Jun 8, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

PAVmed Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

PAVM insider buying and selling by quarter

PAVM insider selling · PAVM insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
2.7M1.4M0
2024 Q4
2025 Q1
2025 Q3
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · PAVM ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

PAVM executive sell shares · PAVM board member insider trading · PAVM insider trading SEC filing

Showing 28 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Lee Victoria Tou-ho

Chief Medical Officer

Award

Date

Apr 2

Shares

70,000

Price

Value

View Form 4 on SEC.gov

Aklog Lishan

Chairman and CEO · Director

Award

Date

Apr 2

Shares

350,000

Price

Value

View Form 4 on SEC.gov

White Debra

Director

Award

Date

Apr 2

Shares

13,930

Price

Value

View Form 4 on SEC.gov

Agrawal Sundeep

Director

Award

Date

Apr 2

Shares

13,930

Price

Value

View Form 4 on SEC.gov

O'Neil Shaun

COO

Award

Date

Apr 2

Shares

110,000

Price

Value

View Form 4 on SEC.gov

Agrawal Sundeep

Director

Award

Date

Sep 30

Shares

150,000

Price

Value

View Form 4 on SEC.gov

Gordon Michael Adam

General Counsel

Award

Date

Sep 30

Shares

150,000

Price

Value

View Form 4 on SEC.gov

MCGRATH DENNIS M

President and CFO

Award

Date

Sep 30

Shares

150,000

Price

Value

View Form 4 on SEC.gov

Aklog Lishan

Chairman and CEO · Director

Award

Date

Sep 30

Shares

150,000

Price

Value

View Form 4 on SEC.gov

O'Neil Shaun

COO

Award

Date

Sep 30

Shares

150,000

Price

Value

View Form 4 on SEC.gov

Glennon Michael J

Director

Purchase

Date

Dec 7

Shares

100,000

Price

$0.62

Value

$62K

View Form 4 on SEC.gov

Glennon Michael J

Director

Purchase

Date

Dec 6

Shares

88,000

Price

$0.64

Value

$56K

View Form 4 on SEC.gov

MCGRATH DENNIS M

President & CFO

Award

Date

Apr 1

Shares

150,000

Price

Value

View Form 4 on SEC.gov

Aklog Lishan

Chairman and CEO · Director

Award

Date

Apr 1

Shares

150,000

Price

Value

View Form 4 on SEC.gov

Aklog Lishan

Chairman and CEO · Director

Purchase

Date

Mar 18

Shares

7,500

Price

$4.31

Value

$32K

View Form 4 on SEC.gov

SIROVICH MATTHEW

10 percent owner

Sale

Date

Nov 24

Shares

53,036

Price

$2.00

Value

$106K

View Form 4 on SEC.gov

SIROVICH MATTHEW

10 percent owner

Sale

Date

Nov 25

Shares

33,203

Price

$1.96

Value

$65K

View Form 4 on SEC.gov

SIROVICH MATTHEW

10 percent owner

Sale

Date

Nov 18

Shares

24,789

Price

$1.78

Value

$44K

View Form 4 on SEC.gov

SIROVICH MATTHEW

10 percent owner

Sale

Date

Nov 19

Shares

75,211

Price

$1.83

Value

$137K

View Form 4 on SEC.gov

SIROVICH MATTHEW

10 percent owner

Sale

Date

May 28

Shares

69,839

Price

$2.06

Value

$144K

View Form 4 on SEC.gov

SIROVICH MATTHEW

10 percent owner

Sale

Date

May 29

Shares

131,082

Price

$1.98

Value

$259K

View Form 4 on SEC.gov

Aklog Lishan

Chairman and CEO · Director

Award

Date

Apr 30

Shares

250,000

Price

Value

View Form 4 on SEC.gov

MCGRATH DENNIS M

President & CFO

Award

Date

Apr 30

Shares

250,000

Price

Value

View Form 4 on SEC.gov

SIROVICH MATTHEW

10 percent owner

Other

Date

Jan 30

Shares

1,199,383

Price

$0.01

Value

$12K

View Form 4 on SEC.gov

MCGRATH DENNIS M

President & CFO

Purchase

Date

May 24

Shares

5,000

Price

$1.09

Value

$5K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About PAVM insider trading

PAVM insider trades

PAVmed Inc. (PAVM) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Aklog Lishan (Chairman and CEO · Director), Agrawal Sundeep (Director), O'Neil Shaun (COO). Over the past 12 months, 5 insiders have filed transactions with the SEC. PAVM insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For PAVmed Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

PAVM insider trading · 5 questions

The insiders of PAVmed Inc. (PAVM) include executives and directors such as Aklog Lishan (Chairman and CEO · Director), Agrawal Sundeep (Director), O'Neil Shaun (COO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

PAVM board member insider tradingwho are PAVM insidersPAVM insider rosterPAVmed Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026